Search clinical trials for: budesonide and montelukast

Total 270322 results

Innovacion y Desarrollo de Estrategias en Salud
National Institute of Pediatrics, Mexico; Laboratorios Senosiain, S.A. de C.V.

Completed

Montelukast and Loratadine in Children With Asthma

Asthma in Children
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients

Perennial Allergic Rhinitis

Korea, Republic of
AstraZeneca
Parexel

Completed

A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers

Study is Being Conducted in Healthy Volunteers

United Kingdom
Assiut University

Not yet recruiting

Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers

Allergic Rhinitis
Organon and Co

Completed

Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396)

Asthma
AstraZeneca

Completed

A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate

Pulmonary Disease, Chronic Obstructive

United Kingdom
Cliniques universitaires Saint-Luc- Université...

Completed

Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit (PSMA)

Prostatic Neoplasm

Belgium
Elpen Pharmaceutical Co. Inc.

Completed

Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek Patients With Asthma During Routine Clinical Practice. (BOREAS)

Quality of Life | Asthma

Greece
Boston Children's Hospital
Brigham and Women's Hospital

Terminated

Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma

Exercise Induced Asthma

United States
Elpen Pharmaceutical Co. Inc.

Completed

Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical Practice (SKIRON)

Quality of Life | Asthma | Satisfaction

Greece
Postgraduate Institute of Medical Education and...

Completed

A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis

India
Temple University

Unknown

Effect of Symbicort on Sleep Quality in Patients With Emphysema

Emphysema | Poor Sleep Quality

United States
Assistance Publique - Hôpitaux de Paris

Completed

Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation (alloforb)

Bronchiolitis Obliterans | Allogeneic Stem Cell Transplantation

France
AstraZeneca

Completed

Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting

Asthma

Netherlands
AstraZeneca

Completed

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

Asthma

Japan
AstraZeneca

Completed

Local Phase 4 Pan-European SMART Study

Asthma

Italy, Sweden, France, Russian Federation, Spain, United Kingdom, Germany, Finland, Norway, Belgium, Netherlands, Greece, Ireland, Iceland
AstraZeneca

Completed

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

Chronic Obstructive Pulmonary Disease

United States, Bulgaria, Germany, Hungary, Romania, Denmark, Greece, Mexico, Iceland
AstraZeneca
Parexel

Completed

Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI HFO Compared With BGF MDI HFA

Chronic Obstructive Pulmonary Disease

United States
AstraZeneca

Completed

Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients (SECURE2)

Chronic Obstructive Pulmonary Disease (COPD)

China
Cairo University

Completed

Oral Glucocorticoids Effect on Post Endodontic Pain

Pulpitis

Egypt
Bayer

Completed

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Melanoma
University of Maryland, Baltimore
Milton S. Hershey Medical Center; Vanderbilt University; Mercy Medical Center

Completed

Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease

Crohn's Disease | IBD

United States
Teva Pharma GmbH

Completed

Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment

Patient Satisfaction

Germany
AstraZeneca

Completed

Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler

COPD Method Evaluation | Chronic Obstructive Pulmonary Disease Method Evaluation

United Kingdom, Sweden
Chiesi Farmaceutici S.p.A.

Completed

Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)

Bronchial Asthma

Austria, Poland, Ukraine
Zhujiang Hospital

Unknown

Differences of Small Airways Function Between Chronic Obstructive Pulmonary Disease(COPD) and Asthma-copd Overlap(ACO)

Quality of Life | Pulmonary Disease, Chronic Obstructive | Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome | Small Airway Disease

China
Zhujiang Hospital

Unknown

Change of Lung Function After Exercise in Patients With Chronic Obstructive Pulmonary Disease

Quality of Life | Pulmonary Disease, Chronic Obstructive | Exercise | Lung Function Decreased

China
Organon and Co

Completed

A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)

Allergic Rhinitis
GlaxoSmithKline

Completed

Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma

Asthma

Bulgaria, Ukraine, Poland
Lawson Health Research Institute

Withdrawn

Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)

Olfactory Disorder

Canada
Zambon SpA
FLUIDDA nv

Completed

Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients

Asthma | Asthma Chronic | Asthmatic | Asthma Bronchial

Belgium
Galera Therapeutics, Inc.

Completed

A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck

Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Oropharynx

United States
Organon and Co

Completed

Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)

Asthma
Damanhour University

Completed

Effect of Pineapple Juice on the Pharmacokinetics of Celecoxib and Montelukast in Humans

Food-drug Interaction

Egypt
University of Arizona

Recruiting

Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease (STOPCLD)

Acute Lung Injury | Chronic Lung Disease of Prematurity | Infant, Extremely Premature | Budesonide

United States
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (Reco-Pilot)

Asthma

Finland
Gelb, Arthur F., M.D.

Recruiting

Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

Asthma

United States
Zhujiang Hospital

Unknown

Small Airways Evaluation and Treatment

Pulmonary Disease，Chronic Obstructive;

China
Intech Biopharm Ltd.

Completed

Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers

Asthma

Taiwan
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation

Outcome

China
GlaxoSmithKline

Completed

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

Asthma

United Kingdom, Germany
Huashan Hospital

Unknown

Efficiency of Budesonide Combined With Formoterol and Tiotropium in the Treatment of Acute Exacerbation of ACO

Asthma-COPD Overlap
AAADRS Clinical Research Center
AstraZeneca

Completed

Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children

Asthma

United States
The Hospital for Sick Children
Merck Frosst Canada Ltd.

Completed

Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma

Asthma, Bronchial

Canada
National Jewish Health

Completed

Sub-Sensitivity to Long-Acting Bronchodilators (LABA)

Asthma

United States
GlaxoSmithKline

Completed

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

Asthma

Canada, Bulgaria, Estonia, Spain, Netherlands, Germany, Australia, Austria, Belgium, Finland, Ireland, Latvia, Macedonia, The Former Yugoslav Republic of, New Zealand, United Kingdom
AstraZeneca

Completed

Comparison Between Symbicort® and Prednisolone in COPD (SPACE)

Chronic Obstructive Pulmonary Disease

Sweden, Germany, Norway, Denmark, Finland
Organon and Co

Completed

Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)

Asthma

3

Subscribe